Estradiol/Norethindrone/Relugolix Shortage Update: What Patients Need to Know in 2026

Is Estradiol/Norethindrone/Relugolix (Myfembree) in Shortage in 2026?

If you've had trouble finding Estradiol/Norethindrone/Relugolix — sold under the brand name Myfembree — you might be wondering: Is there a drug shortage? The answer is nuanced.

As of early 2026, Myfembree is not on the FDA's official drug shortage list. The medication is being actively manufactured by Myovant Sciences, and there are no reported manufacturing disruptions or supply chain problems.

However, many patients are still having difficulty filling their prescriptions. The challenge isn't about supply — it's about access.

Why Is Myfembree Still Hard to Find?

Even without a formal shortage, several factors make Myfembree difficult to locate at your local pharmacy:

Specialty Medication Status

Myfembree is a specialty drug that treats specific conditions — heavy menstrual bleeding from uterine fibroids and moderate to severe endometriosis pain. Unlike widely prescribed medications like blood pressure or cholesterol drugs, the patient population for Myfembree is relatively small. Most retail pharmacies don't stock medications with low prescription volume. For a detailed breakdown, read why Estradiol/Norethindrone/Relugolix is so hard to find.

High Cost Deters Pharmacy Stocking

With a cash price of $1,300 to $1,700 per month, Myfembree is expensive for pharmacies to keep on their shelves. If a patient doesn't pick up the medication or insurance denies coverage, the pharmacy absorbs a significant financial loss. This makes pharmacies cautious about stocking it without a confirmed, approved prescription.

Insurance Prior Authorization Requirements

Most insurance plans require prior authorization before covering Myfembree. Some also require step therapy, meaning you need to try other treatments first (such as hormonal contraceptives or a hormonal IUD). These requirements add delays to the process and discourage pharmacies from ordering the medication preemptively.

No Generic Available Yet

As of March 2026, there is no FDA-approved generic version of Myfembree. While some patent exclusivities have begun expiring, no generic manufacturer has launched a product yet. This means the brand-name version from Myovant Sciences is the only option, concentrating the supply through a single manufacturer.

What Does Myfembree Cost in 2026?

Here's a breakdown of Myfembree costs in 2026:

• Cash price (without insurance): $1,300–$1,700 per 28-tablet supply (one month)
• With commercial insurance + copay card: As low as $5 per monthly fill through the Myfembree Copay Assistance Program (up to $5,000 annual maximum)
• With insurance (no copay card): Varies widely based on your plan — could be $30–$300+ depending on your formulary tier and deductible
• MedFinder savings card — our free discount card with low prices at 65,000+ pharmacies nationwide. Search your medication, compare the cash price near you, and show the card at the counter to save up to 80%. It's a discount, not insurance, and savings vary by drug and pharmacy. Note: pharmacies can choose not to participate. You can use it whether you find your medication with MedFinder or not.

For a complete guide on saving money, see how to save money on Estradiol/Norethindrone/Relugolix in 2026.

Are There Any New Options in 2026?

While no generic Myfembree is available yet, the drug landscape for uterine fibroids and endometriosis continues to evolve. Key developments to watch:

• Potential generic entry: Patent exclusivities have been expiring, and generic manufacturers could potentially receive FDA approval in 2026. A generic version would significantly lower the cost and improve availability.
• Expanded telehealth prescribing: More OB/GYN specialists are offering telehealth consultations, making it easier to get prescribed and start treatment without in-person visits. Find a prescriber through our guide on finding a doctor who prescribes Estradiol/Norethindrone/Relugolix.
• Growing awareness: As more patients and providers become familiar with Myfembree (it was expanded to endometriosis in 2023), pharmacy stocking may gradually improve.

42,670+ patients found their medications in stock

42K+

Find Estradiol/Norethindrone In Stock Today →

How to Find Estradiol/Norethindrone/Relugolix in Stock

Here are the most effective strategies for locating Myfembree:

1. Use Medfinder

Medfinder helps you search for pharmacies that have Estradiol/Norethindrone/Relugolix in stock near your location. It can save you significant time compared to calling pharmacies individually.

2. Contact Specialty Pharmacies

Specialty pharmacies like CVS Specialty, Accredo, and AllianceRx Walgreens routinely stock Myfembree. Your insurance plan may even require you to use a specialty pharmacy for this medication. Check with your insurance company or doctor's office for your designated specialty pharmacy.

3. Try Independent Pharmacies

Locally owned pharmacies may be more willing to order Myfembree for you. They can typically get it within 1–2 business days from their wholesaler. For a complete list of tips, read how to find Estradiol/Norethindrone/Relugolix in stock near you.

4. Consider Mail-Order Options

Many insurance plans offer mail-order specialty pharmacy services. The medication is shipped directly to your home, bypassing local availability issues entirely.

5. Plan Ahead

Request refills 7–10 days before you run out. This gives the pharmacy time to order the medication and resolve any insurance issues.

Final Thoughts

Estradiol/Norethindrone/Relugolix (Myfembree) is not in a formal shortage, but it remains challenging to find at many pharmacies due to its specialty status, high cost, and insurance requirements. The medication is being manufactured and is available — you just need to know where to look.

Use tools like Medfinder, work with specialty pharmacies, plan ahead on refills, and explore the manufacturer's savings programs. If Myfembree continues to be inaccessible, talk to your doctor about alternative treatments that may be easier to fill.

For information on side effects and drug interactions, check our other guides in this series.